Structure

Physi-Chem Properties

Molecular Weight:  558.25
Volume:  565.941
LogP:  3.879
LogD:  3.236
LogS:  -4.58
# Rotatable Bonds:  10
TPSA:  118.98
# H-Bond Aceptor:  10
# H-Bond Donor:  1
# Rings:  3
# Heavy Atoms:  10

MedChem Properties

QED Drug-Likeness Score:  0.327
Synthetic Accessibility Score:  4.252
Fsp3:  0.467
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  1
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.744
MDCK Permeability:  2.366447552049067e-05
Pgp-inhibitor:  0.998
Pgp-substrate:  0.001
Human Intestinal Absorption (HIA):  0.035
20% Bioavailability (F20%):  0.0
30% Bioavailability (F30%):  0.078

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.032
Plasma Protein Binding (PPB):  64.82369232177734%
Volume Distribution (VD):  0.806
Pgp-substrate:  27.36029624938965%

ADMET: Metabolism

CYP1A2-inhibitor:  0.021
CYP1A2-substrate:  0.971
CYP2C19-inhibitor:  0.81
CYP2C19-substrate:  0.938
CYP2C9-inhibitor:  0.897
CYP2C9-substrate:  0.639
CYP2D6-inhibitor:  0.046
CYP2D6-substrate:  0.396
CYP3A4-inhibitor:  0.716
CYP3A4-substrate:  0.922

ADMET: Excretion

Clearance (CL):  5.031
Half-life (T1/2):  0.167

ADMET: Toxicity

hERG Blockers:  0.342
Human Hepatotoxicity (H-HT):  0.088
Drug-inuced Liver Injury (DILI):  0.919
AMES Toxicity:  0.06
Rat Oral Acute Toxicity:  0.324
Maximum Recommended Daily Dose:  0.017
Skin Sensitization:  0.075
Carcinogencity:  0.016
Eye Corrosion:  0.003
Eye Irritation:  0.093
Respiratory Toxicity:  0.579

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC474393

Natural Product ID:  NPC474393
Common Name*:   Kadangustin G
IUPAC Name:   n.a.
Synonyms:   Kadangustin G
Standard InCHIKey:  MLZWZUMLLVUXMT-HMCQAFCPSA-N
Standard InCHI:  InChI=1S/C30H38O10/c1-11-14(2)30(33)40-26-16(4)15(3)25(39-17(5)31)19-13-21(35-7)28(37-9)29(38-10)23(19)22-18(26)12-20(34-6)27(36-8)24(22)32/h11-13,15-16,25-26,32H,1-10H3/b14-11+/t15-,16+,25+,26+/m1/s1
SMILES:  C/C=C(/C(=O)O[C@H]1[C@@H](C)[C@@H](C)[C@H](OC(=O)C)c2c(c3c1cc(OC)c(c3O)OC)c(OC)c(c(c2)OC)OC)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL465863
PubChem CID:   24861900
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0000238] Tannins
        • [CHEMONTID:0001710] Hydrolyzable tannins

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO18146 Kadsura angustifolia Species Schisandraceae Eukaryota stems Honghe Prefecture of Yunnan Province, China 2005-Oct PMID[18278869]
NPO18146 Kadsura angustifolia Species Schisandraceae Eukaryota n.a. n.a. n.a. PMID[21232955]
NPO18146 Kadsura angustifolia Species Schisandraceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO18146 Kadsura angustifolia Species Schisandraceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT1452 Cell Line C8166 Homo sapiens CC50 = 72240.0 nM PMID[493765]
NPT24 Organism Human immunodeficiency virus 1 Human immunodeficiency virus 1 EC50 = 25730.0 nM PMID[493765]
NPT2 Others Unspecified Ratio = 2.81 n.a. PMID[493765]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC474393 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC474347
0.993 High Similarity NPC470916
0.9724 High Similarity NPC149735
0.9718 High Similarity NPC295297
0.9648 High Similarity NPC474054
0.9645 High Similarity NPC87883
0.9592 High Similarity NPC476065
0.9589 High Similarity NPC475141
0.9524 High Similarity NPC473736
0.9517 High Similarity NPC477381
0.9463 High Similarity NPC475592
0.9452 High Similarity NPC477379
0.9388 High Similarity NPC471154
0.9324 High Similarity NPC297271
0.9324 High Similarity NPC126405
0.9324 High Similarity NPC53669
0.9324 High Similarity NPC77237
0.9324 High Similarity NPC16791
0.9324 High Similarity NPC308739
0.9324 High Similarity NPC474606
0.9324 High Similarity NPC217708
0.9324 High Similarity NPC24562
0.932 High Similarity NPC475756
0.931 High Similarity NPC183083
0.931 High Similarity NPC137352
0.9291 High Similarity NPC471183
0.9272 High Similarity NPC230531
0.9272 High Similarity NPC215400
0.9247 High Similarity NPC477879
0.922 High Similarity NPC865
0.9216 High Similarity NPC473445
0.9216 High Similarity NPC42797
0.92 High Similarity NPC238834
0.9189 High Similarity NPC224472
0.9156 High Similarity NPC291977
0.9149 High Similarity NPC133025
0.9139 High Similarity NPC473323
0.9133 High Similarity NPC198461
0.9133 High Similarity NPC312763
0.9116 High Similarity NPC477375
0.9116 High Similarity NPC198129
0.9116 High Similarity NPC327352
0.9116 High Similarity NPC252281
0.9085 High Similarity NPC301765
0.9085 High Similarity NPC156948
0.9085 High Similarity NPC46277
0.9085 High Similarity NPC3072
0.9085 High Similarity NPC86605
0.9054 High Similarity NPC322426
0.9054 High Similarity NPC477376
0.9054 High Similarity NPC477374
0.9034 High Similarity NPC469630
0.9013 High Similarity NPC469474
0.9007 High Similarity NPC188378
0.9007 High Similarity NPC7515
0.9007 High Similarity NPC276026
0.9007 High Similarity NPC56764
0.9007 High Similarity NPC289258
0.9007 High Similarity NPC555
0.9007 High Similarity NPC206737
0.9007 High Similarity NPC469659
0.8993 High Similarity NPC316989
0.8986 High Similarity NPC252402
0.8986 High Similarity NPC316676
0.8986 High Similarity NPC102934
0.8986 High Similarity NPC325720
0.8944 High Similarity NPC240279
0.8944 High Similarity NPC214853
0.8944 High Similarity NPC55239
0.8944 High Similarity NPC180602
0.8926 High Similarity NPC85141
0.8919 High Similarity NPC178129
0.8912 High Similarity NPC327651
0.8912 High Similarity NPC318286
0.8882 High Similarity NPC473425
0.8867 High Similarity NPC473989
0.8861 High Similarity NPC311912
0.8851 High Similarity NPC321696
0.8851 High Similarity NPC321958
0.8846 High Similarity NPC249070
0.8844 High Similarity NPC73467
0.8844 High Similarity NPC121661
0.8844 High Similarity NPC326144
0.8816 High Similarity NPC477377
0.8805 High Similarity NPC88557
0.8794 High Similarity NPC184928
0.8794 High Similarity NPC141493
0.8784 High Similarity NPC110763
0.8784 High Similarity NPC189239
0.8784 High Similarity NPC197352
0.8784 High Similarity NPC166506
0.8776 High Similarity NPC76415
0.8776 High Similarity NPC218510
0.8766 High Similarity NPC29727
0.875 High Similarity NPC475229
0.875 High Similarity NPC476434
0.875 High Similarity NPC272566
0.875 High Similarity NPC477378
0.8742 High Similarity NPC24425
0.8741 High Similarity NPC135127
0.8733 High Similarity NPC187398
0.8733 High Similarity NPC476348
0.8732 High Similarity NPC102256
0.8725 High Similarity NPC154971
0.8725 High Similarity NPC40222
0.8725 High Similarity NPC268515
0.8725 High Similarity NPC252286
0.8718 High Similarity NPC24627
0.871 High Similarity NPC125495
0.8707 High Similarity NPC184684
0.8707 High Similarity NPC67467
0.8707 High Similarity NPC184641
0.8707 High Similarity NPC133934
0.8701 High Similarity NPC476642
0.8693 High Similarity NPC65591
0.8693 High Similarity NPC178574
0.869 High Similarity NPC281780
0.8679 High Similarity NPC83049
0.8679 High Similarity NPC118162
0.8679 High Similarity NPC320471
0.8675 High Similarity NPC176903
0.8675 High Similarity NPC30688
0.8671 High Similarity NPC469518
0.8671 High Similarity NPC469475
0.8667 High Similarity NPC476347
0.8658 High Similarity NPC477702
0.8658 High Similarity NPC163898
0.8654 High Similarity NPC328122
0.8649 High Similarity NPC324962
0.8649 High Similarity NPC477697
0.8649 High Similarity NPC6568
0.8649 High Similarity NPC477696
0.8649 High Similarity NPC470811
0.8645 High Similarity NPC477380
0.8636 High Similarity NPC178195
0.8636 High Similarity NPC348849
0.863 High Similarity NPC114171
0.863 High Similarity NPC230124
0.863 High Similarity NPC6300
0.8621 High Similarity NPC471988
0.8621 High Similarity NPC471719
0.8618 High Similarity NPC120426
0.8618 High Similarity NPC21184
0.8618 High Similarity NPC294522
0.8618 High Similarity NPC205727
0.8611 High Similarity NPC326095
0.8611 High Similarity NPC244983
0.8611 High Similarity NPC67247
0.8609 High Similarity NPC236166
0.8609 High Similarity NPC473408
0.8608 High Similarity NPC469512
0.8601 High Similarity NPC175067
0.8601 High Similarity NPC204215
0.86 High Similarity NPC212890
0.8592 High Similarity NPC126836
0.8591 High Similarity NPC16353
0.859 High Similarity NPC477885
0.8582 High Similarity NPC283114
0.8582 High Similarity NPC207702
0.8582 High Similarity NPC149008
0.8581 High Similarity NPC469564
0.8581 High Similarity NPC131971
0.8581 High Similarity NPC229172
0.8581 High Similarity NPC36531
0.8581 High Similarity NPC470917
0.8581 High Similarity NPC103637
0.8581 High Similarity NPC230538
0.8571 High Similarity NPC267291
0.8571 High Similarity NPC109240
0.8571 High Similarity NPC470769
0.8562 High Similarity NPC105493
0.8553 High Similarity NPC125570
0.8553 High Similarity NPC106138
0.8553 High Similarity NPC475250
0.8552 High Similarity NPC165155
0.8552 High Similarity NPC256262
0.8552 High Similarity NPC24490
0.8552 High Similarity NPC141765
0.8552 High Similarity NPC34103
0.8542 High Similarity NPC32778
0.8542 High Similarity NPC158331
0.8533 High Similarity NPC475868
0.8531 High Similarity NPC474017
0.8531 High Similarity NPC470095
0.8531 High Similarity NPC470096
0.8526 High Similarity NPC227062
0.8523 High Similarity NPC34245
0.8523 High Similarity NPC91492
0.8523 High Similarity NPC256555
0.8523 High Similarity NPC273657
0.8523 High Similarity NPC106920
0.8523 High Similarity NPC7439
0.8523 High Similarity NPC110067
0.8516 High Similarity NPC197188
0.8516 High Similarity NPC43872
0.8516 High Similarity NPC291510
0.8516 High Similarity NPC116850
0.8516 High Similarity NPC7178
0.8516 High Similarity NPC238672
0.8516 High Similarity NPC144801

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC474393 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8418 Intermediate Similarity NPD6234 Discontinued
0.8392 Intermediate Similarity NPD3027 Phase 3
0.8291 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.8217 Intermediate Similarity NPD37 Approved
0.8176 Intermediate Similarity NPD4966 Approved
0.8176 Intermediate Similarity NPD4965 Approved
0.8176 Intermediate Similarity NPD4967 Phase 2
0.8171 Intermediate Similarity NPD7228 Approved
0.8165 Intermediate Similarity NPD1465 Phase 2
0.811 Intermediate Similarity NPD7473 Discontinued
0.8095 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.8095 Intermediate Similarity NPD1613 Approved
0.8077 Intermediate Similarity NPD1653 Approved
0.8037 Intermediate Similarity NPD6232 Discontinued
0.8012 Intermediate Similarity NPD5844 Phase 1
0.8 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7987 Intermediate Similarity NPD1934 Approved
0.7945 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7895 Intermediate Similarity NPD7266 Discontinued
0.7866 Intermediate Similarity NPD7199 Phase 2
0.7852 Intermediate Similarity NPD4060 Phase 1
0.7826 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.7778 Intermediate Similarity NPD3817 Phase 2
0.7771 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7751 Intermediate Similarity NPD7074 Phase 3
0.7738 Intermediate Similarity NPD3818 Discontinued
0.773 Intermediate Similarity NPD3882 Suspended
0.7727 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7725 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.7725 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.7725 Intermediate Similarity NPD6166 Phase 2
0.7724 Intermediate Similarity NPD4379 Clinical (unspecified phase)
0.7716 Intermediate Similarity NPD2801 Approved
0.7716 Intermediate Similarity NPD7819 Suspended
0.7706 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7692 Intermediate Similarity NPD7054 Approved
0.7688 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7683 Intermediate Similarity NPD7075 Discontinued
0.7682 Intermediate Similarity NPD230 Phase 1
0.7661 Intermediate Similarity NPD7240 Approved
0.7647 Intermediate Similarity NPD7472 Approved
0.7628 Intermediate Similarity NPD3750 Approved
0.7628 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.76 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7584 Intermediate Similarity NPD4908 Phase 1
0.758 Intermediate Similarity NPD6190 Approved
0.7557 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7531 Intermediate Similarity NPD4380 Phase 2
0.7517 Intermediate Similarity NPD3018 Phase 2
0.7514 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD1940 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.7484 Intermediate Similarity NPD1511 Approved
0.7483 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7466 Intermediate Similarity NPD422 Phase 1
0.7466 Intermediate Similarity NPD1610 Phase 2
0.7457 Intermediate Similarity NPD7251 Discontinued
0.7453 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7452 Intermediate Similarity NPD6674 Discontinued
0.7451 Intermediate Similarity NPD6355 Discontinued
0.744 Intermediate Similarity NPD8127 Discontinued
0.7438 Intermediate Similarity NPD2534 Approved
0.7438 Intermediate Similarity NPD2533 Approved
0.7438 Intermediate Similarity NPD2532 Approved
0.7436 Intermediate Similarity NPD5763 Approved
0.7436 Intermediate Similarity NPD5762 Approved
0.7429 Intermediate Similarity NPD7090 Clinical (unspecified phase)
0.7417 Intermediate Similarity NPD4625 Phase 3
0.7414 Intermediate Similarity NPD7549 Discontinued
0.7414 Intermediate Similarity NPD7808 Phase 3
0.741 Intermediate Similarity NPD7768 Phase 2
0.7405 Intermediate Similarity NPD4628 Phase 3
0.7399 Intermediate Similarity NPD6797 Phase 2
0.7391 Intermediate Similarity NPD1512 Approved
0.7391 Intermediate Similarity NPD7314 Clinical (unspecified phase)
0.7386 Intermediate Similarity NPD3620 Phase 2
0.7386 Intermediate Similarity NPD3619 Clinical (unspecified phase)
0.7381 Intermediate Similarity NPD5494 Approved
0.7375 Intermediate Similarity NPD6799 Approved
0.7375 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7372 Intermediate Similarity NPD2935 Discontinued
0.7365 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.7365 Intermediate Similarity NPD2982 Phase 2
0.7365 Intermediate Similarity NPD2983 Phase 2
0.7356 Intermediate Similarity NPD7685 Pre-registration
0.7356 Intermediate Similarity NPD6559 Discontinued
0.7349 Intermediate Similarity NPD5402 Approved
0.7347 Intermediate Similarity NPD3705 Approved
0.7342 Intermediate Similarity NPD1652 Phase 2
0.7338 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.7338 Intermediate Similarity NPD5124 Phase 1
0.7337 Intermediate Similarity NPD6959 Discontinued
0.7333 Intermediate Similarity NPD6801 Discontinued
0.7333 Intermediate Similarity NPD6917 Clinical (unspecified phase)
0.7329 Intermediate Similarity NPD4626 Approved
0.7324 Intermediate Similarity NPD5283 Phase 1
0.7322 Intermediate Similarity NPD7237 Clinical (unspecified phase)
0.7317 Intermediate Similarity NPD6599 Discontinued
0.7308 Intermediate Similarity NPD3748 Approved
0.7297 Intermediate Similarity NPD2981 Phase 2
0.7296 Intermediate Similarity NPD8166 Discontinued
0.7294 Intermediate Similarity NPD7229 Phase 3
0.7285 Intermediate Similarity NPD2861 Phase 2
0.7267 Intermediate Similarity NPD4357 Discontinued
0.7262 Intermediate Similarity NPD7975 Clinical (unspecified phase)
0.7261 Intermediate Similarity NPD2438 Suspended
0.7261 Intermediate Similarity NPD6100 Approved
0.7261 Intermediate Similarity NPD6099 Approved
0.726 Intermediate Similarity NPD5691 Approved
0.7255 Intermediate Similarity NPD6410 Clinical (unspecified phase)
0.7248 Intermediate Similarity NPD4749 Approved
0.7246 Intermediate Similarity NPD5353 Approved
0.7246 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.7241 Intermediate Similarity NPD5536 Phase 2
0.7239 Intermediate Similarity NPD5403 Approved
0.7207 Intermediate Similarity NPD6843 Phase 3
0.7207 Intermediate Similarity NPD6842 Approved
0.7207 Intermediate Similarity NPD6841 Approved
0.7197 Intermediate Similarity NPD1510 Phase 2
0.7192 Intermediate Similarity NPD1548 Phase 1
0.719 Intermediate Similarity NPD7095 Approved
0.7188 Intermediate Similarity NPD4109 Clinical (unspecified phase)
0.7188 Intermediate Similarity NPD4110 Phase 3
0.7183 Intermediate Similarity NPD228 Approved
0.717 Intermediate Similarity NPD1549 Phase 2
0.7169 Intermediate Similarity NPD5090 Approved
0.7169 Intermediate Similarity NPD7411 Suspended
0.7169 Intermediate Similarity NPD5089 Approved
0.7169 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.7166 Intermediate Similarity NPD7680 Approved
0.7161 Intermediate Similarity NPD1240 Approved
0.7152 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7152 Intermediate Similarity NPD2797 Approved
0.7152 Intermediate Similarity NPD1551 Phase 2
0.7151 Intermediate Similarity NPD5242 Approved
0.7143 Intermediate Similarity NPD6798 Discontinued
0.7133 Intermediate Similarity NPD3600 Clinical (unspecified phase)
0.7126 Intermediate Similarity NPD3751 Discontinued
0.7125 Intermediate Similarity NPD5698 Clinical (unspecified phase)
0.7118 Intermediate Similarity NPD919 Approved
0.7117 Intermediate Similarity NPD5401 Approved
0.7117 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7117 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.7115 Intermediate Similarity NPD447 Suspended
0.711 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7107 Intermediate Similarity NPD2029 Clinical (unspecified phase)
0.7107 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.7107 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.7088 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7086 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.7086 Intermediate Similarity NPD1283 Approved
0.7083 Intermediate Similarity NPD8455 Phase 2
0.7079 Intermediate Similarity NPD8313 Approved
0.7079 Intermediate Similarity NPD8312 Approved
0.707 Intermediate Similarity NPD1607 Approved
0.707 Intermediate Similarity NPD6653 Approved
0.7059 Intermediate Similarity NPD3749 Approved
0.7056 Intermediate Similarity NPD8434 Phase 2
0.7052 Intermediate Similarity NPD3926 Phase 2
0.7051 Intermediate Similarity NPD2979 Phase 3
0.7051 Intermediate Similarity NPD943 Approved
0.7048 Intermediate Similarity NPD4005 Discontinued
0.7047 Intermediate Similarity NPD3496 Discontinued
0.7044 Intermediate Similarity NPD2796 Approved
0.7042 Intermediate Similarity NPD3021 Approved
0.7042 Intermediate Similarity NPD3022 Approved
0.7037 Intermediate Similarity NPD5307 Clinical (unspecified phase)
0.7032 Intermediate Similarity NPD3268 Approved
0.7025 Intermediate Similarity NPD7097 Phase 1
0.7019 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7012 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.7 Intermediate Similarity NPD3540 Phase 1
0.6994 Remote Similarity NPD3787 Discontinued
0.6987 Remote Similarity NPD6233 Phase 2
0.6979 Remote Similarity NPD8151 Discontinued
0.6975 Remote Similarity NPD1878 Clinical (unspecified phase)
0.6975 Remote Similarity NPD7003 Approved
0.6964 Remote Similarity NPD6386 Approved
0.6964 Remote Similarity NPD6385 Approved
0.6959 Remote Similarity NPD4055 Discovery
0.6954 Remote Similarity NPD1608 Approved
0.6954 Remote Similarity NPD9269 Phase 2
0.6948 Remote Similarity NPD9494 Approved
0.6946 Remote Similarity NPD6055 Clinical (unspecified phase)
0.6946 Remote Similarity NPD3226 Approved
0.6943 Remote Similarity NPD4140 Approved
0.6941 Remote Similarity NPD6374 Clinical (unspecified phase)
0.6937 Remote Similarity NPD3539 Phase 1
0.6937 Remote Similarity NPD6032 Approved
0.6923 Remote Similarity NPD3764 Approved
0.6909 Remote Similarity NPD7410 Clinical (unspecified phase)
0.6909 Remote Similarity NPD7446 Clinical (unspecified phase)
0.6903 Remote Similarity NPD6832 Phase 2
0.6901 Remote Similarity NPD1358 Approved
0.6899 Remote Similarity NPD4340 Discontinued
0.6897 Remote Similarity NPD5711 Approved
0.6897 Remote Similarity NPD5710 Approved
0.689 Remote Similarity NPD6666 Approved
0.689 Remote Similarity NPD6667 Approved
0.689 Remote Similarity NPD7124 Phase 2

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data